Vaxart Inc (VXRT)
0.7651
+0.04
(+4.97%)
USD |
NASDAQ |
May 06, 16:00
0.7651
0.00 (0.00%)
After-Hours: 18:40
Vaxart Revenue (TTM): 9.104M for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 9.104M |
| September 30, 2023 | 2.501M |
| June 30, 2023 | |
| March 31, 2023 | |
| December 31, 2022 | |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | 0.471M |
| December 31, 2021 | 0.892M |
| September 30, 2021 | 1.174M |
| June 30, 2021 | 1.239M |
| March 31, 2021 | 1.65M |
| December 31, 2020 | 4.046M |
| September 30, 2020 | 7.606M |
| June 30, 2020 | 7.795M |
| March 31, 2020 | 7.357M |
| December 31, 2019 | 9.862M |
| September 30, 2019 | 7.713M |
| June 30, 2019 | 7.54M |
| March 31, 2019 | 8.063M |
| December 31, 2018 | 4.159M |
| September 30, 2018 | 5.092M |
| June 30, 2018 | 4.911M |
| March 31, 2018 | 4.403M |
| December 31, 2017 | 7.80M |
| Date | Value |
|---|---|
| September 30, 2017 | 8.90M |
| June 30, 2017 | 8.90M |
| March 31, 2017 | 9.30M |
| December 31, 2016 | 9.70M |
| September 30, 2016 | 7.60M |
| June 30, 2016 | 9.20M |
| March 31, 2016 | 12.80M |
| December 31, 2015 | 13.40M |
| September 30, 2015 | 25.60M |
| June 30, 2015 | 24.60M |
| March 31, 2015 | 28.90M |
| December 31, 2014 | 52.50M |
| September 30, 2014 | 57.10M |
| June 30, 2014 | 68.70M |
| March 31, 2014 | 69.55M |
| December 31, 2013 | 52.55M |
| September 30, 2013 | 44.44M |
| June 30, 2013 | 32.77M |
| March 31, 2013 | 24.14M |
| December 31, 2012 | 12.28M |
| September 30, 2012 | 2.73M |
| June 30, 2012 | 3.184M |
| March 31, 2012 | 6.297M |
| December 31, 2011 | 14.84M |
| September 30, 2011 | 18.08M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
0.471M
Minimum
Mar 2022
9.862M
Maximum
Dec 2019
4.925M
Average
5.702M
Median
Revenue (TTM) Benchmarks
| Novavax Inc | 693.46M |
| aTyr Pharma Inc | -- |
| Allogene Therapeutics Inc | 0.095M |
| AIM ImmunoTech Inc | 0.202M |
| Protalix BioTherapeutics Inc | 65.49M |